Company profile
Abliva AB company profile
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.
Business identity
- Website
- https://abliva.com/
- Contact email
- [email protected]
- Phone number
- +46 (0)46-275 62 20
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2000-01-01
Headquarters
- Headquarters
- Byumba, Northern Province, Rwanda
- Postal code
- 223 81
- Country code
- RW
- Continent
- Africa